Literature DB >> 33209480

Factors associated with worse outcomes for colorectal neuroendocrine tumors in radical versus local resections.

Osayande Osagiede1, Elizabeth Habermann2, Courtney Day2, Emmanuel Gabriel3, Amit Merchea3, Riccardo Lemini3, Iktej S Jabbal3, Dorin T Colibaseanu3.   

Abstract

BACKGROUND: Colorectal neuroendocrine tumors (NETs) are the most common NETs of the gastrointestinal tract. Due to the rarity, colorectal NETs are understudied and are not clearly understood. Our study sought to identify the factors associated with worse outcomes for colorectal NETs following resection.
METHODS: We identified patients diagnosed with colorectal NETs [2004-2014] who underwent resection from the National Cancer Data Base. Non-NETs were excluded. Overall survival (OS) was evaluated using the Kaplan Meier method. Cox proportional hazards and logistic regression models were used to assess factors associated with radical versus local resection, OS and LOS.
RESULTS: A total of 7,967 colon and 11,929 rectal NETs were analyzed. The majority of colon (93.4%) and rectal (89.1%) NETs underwent radical and local resection respectively. The 5-year OS was 69% and 92% for colon and rectal NETs respectively. Older age (OR 1.45, CI 1.37-1.53) and clinical stage 4 (OR 9.91, CI 4.56-21.52) were associated with higher odds for colonic radical resection. Lowest median income quartile (OR 1.41, CI 1.21-1.64) and African Americans (OR 1.26, CI 1.07-1.49) experienced higher mortality for colon and rectal NETs respectively.
CONCLUSIONS: Racial minority and low-income patients experience worse outcomes for colorectal NETs following resection. 2020 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  National Cancer Data Base; Neuroendocrine neoplasms; colorectal cancer; endoscopic resection; neuroendocrine carcinoma (NEC); neuroendocrine tumors (NETs); outcomes; radical resection

Year:  2020        PMID: 33209480      PMCID: PMC7657829          DOI: 10.21037/jgo-20-193

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  24 in total

1.  Tumor size and depth predict rate of lymph node metastasis in colon carcinoids and can be used to select patients for endoscopic resection.

Authors:  Riad H Al Natour; Mandeep S Saund; Vivian M Sanchez; Edward E Whang; Ashish M Sharma; Qin Huang; Valia A Boosalis; Jason S Gold
Journal:  J Gastrointest Surg       Date:  2011-12-06       Impact factor: 3.452

Review 2.  Rectal carcinoids are on the rise: early detection by screening endoscopy.

Authors:  H Scherübl
Journal:  Endoscopy       Date:  2009-02-12       Impact factor: 10.093

3.  Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years.

Authors:  Tsuyoshi Konishi; Toshiaki Watanabe; Junji Kishimoto; Kenjiro Kotake; Tetsuichiro Muto; Hirokazu Nagawa
Journal:  Gut       Date:  2007-01-09       Impact factor: 23.059

4.  Treatment strategy for rectal carcinoids: a clinicopathological analysis of 229 cases at a single cancer institution.

Authors:  Akiyoshi Kasuga; Akiko Chino; Naoyuki Uragami; Teruhito Kishihara; Masahiro Igarashi; Rikiya Fujita; Noriko Yamamoto; Masashi Ueno; Masatoshi Oya; Tetsuichiro Muto
Journal:  J Gastroenterol Hepatol       Date:  2012-12       Impact factor: 4.029

5.  Prevalence of metastasis and survival of 788 patients with T1 rectal carcinoid tumors.

Authors:  Saowanee Ngamruengphong; Ayesha Kamal; Venkata Akshintala; Gulara Hajiyeva; Yuri Hanada; Yen-I Chen; Omid Sanaei; Daniela Fluxa; Yamile Haito Chavez; Vivek Kumbhari; Vikesh K Singh; Anne Marie Lennon; Marcia Irene Canto; Mouen A Khashab
Journal:  Gastrointest Endosc       Date:  2018-11-14       Impact factor: 9.427

6.  Endoscopically identified well-differentiated rectal carcinoid tumors: impact of tumor size on the natural history and outcomes.

Authors:  Ferga C Gleeson; Michael J Levy; Eric J Dozois; David W Larson; Louis Michel Wong Kee Song; Lisa A Boardman
Journal:  Gastrointest Endosc       Date:  2014-01-23       Impact factor: 9.427

7.  A 5-decade analysis of 13,715 carcinoid tumors.

Authors:  Irvin M Modlin; Kevin D Lye; Mark Kidd
Journal:  Cancer       Date:  2003-02-15       Impact factor: 6.860

8.  Updated population-based review of carcinoid tumors.

Authors:  Melinda A Maggard; Jessica B O'Connell; Clifford Y Ko
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

Review 9.  Small Bowel and Colorectal Carcinoids.

Authors:  Raphael M Byrne; Rodney F Pommier
Journal:  Clin Colon Rectal Surg       Date:  2018-09-04

10.  Local excision results in comparable survival to radical resection for early-stage rectal carcinoid.

Authors:  Brian Ezekian; Mohamad A Adam; Megan C Turner; Brian F Gilmore; Kyle Freischlag; Harold J Leraas; Christopher R Mantyh; John Migaly
Journal:  J Surg Res       Date:  2018-05-14       Impact factor: 2.192

View more
  3 in total

Review 1.  Rectal neuroendocrine neoplasms: what the radiologists should know.

Authors:  Mayur Virarkar; Dheeraj R Gopireddy; Ajaykumar C Morani; Ahmad Alkhasawneh; Sergio Piotr Klimkowski; Sindhu Kumar; Chandana Lall; Priya Bhosale
Journal:  Abdom Radiol (NY)       Date:  2022-03-14

Review 2.  Diagnosis and Management of Rectal Neuroendocrine Tumors (NETs).

Authors:  Francesco Maione; Alessia Chini; Marco Milone; Nicola Gennarelli; Michele Manigrasso; Rosa Maione; Gianluca Cassese; Gianluca Pagano; Francesca Paola Tropeano; Gaetano Luglio; Giovanni Domenico De Palma
Journal:  Diagnostics (Basel)       Date:  2021-04-25

Review 3.  Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance.

Authors:  Camilla Gallo; Roberta Elisa Rossi; Federica Cavalcoli; Federico Barbaro; Ivo Boškoski; Pietro Invernizzi; Sara Massironi
Journal:  World J Gastroenterol       Date:  2022-03-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.